Q14What was the design of the MRC trial of TB spine?▸
Series of studies since 1965 in multiple centres worldwide; follow-up up to 15 years
Korea - Masan: inpatient 6 months bed rest vs outpatient; Pusan: POP jacket vs no jacket
Hong Kong: radical debridement + graft vs debridement; Bulawayo: nonoperative vs operative debridement
Inclusion: clinical and radiological TB, T1-S1 disease
Exclusions: significant neurological deficit (unable to walk room length), significant extraspinal disease, >3 levels of destruction, C spine, anti-TB drugs >1 year
All had anti-TB drugs (PASINAH)
Q15What was a favourable outcome in the MRC trial and what did it conclude?▸
Favourable outcome: no symptoms, full physical activity, no CNS involvement, no sinus/abscess, radiological healing; assessed at 5, 10, 15 years
POP jacket not required (Pusan)
Outpatient antibiotics without bedrest are OK (Masan)
Kyphus with sequestrum >5mm and adjacent segment stenosis
Cord atrophy/syringomyelia
Q19What are the surgical approaches and deformity correction options in TB spine?▸
Approach - anterior: above T4 equal from either side (usually from the side with the large abscess); below T4 from the left; thoracotomy with rib resection 2 levels above
Q49Which other classification systems are used for spine tumours?▸
Tomita
Weinstein, Boriani, Biagini (WBB)
Fact check
Dexamethasone 50mg loading dose for metastatic spinal cord compression (lecture notes) — non-standard dose, likely error — Guidelines recommend an initial 10mg IV loading dose followed by 4mg (or 6-10mg) every 6 hours; a 50mg bolus is not a recognised regimen — (medium confidence) — source